Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ramon Alemany

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
Cancer Research|July 12, 2018
Remission of Spontaneous Canine Tumors after Systemic Cellular ViroimmunotherapyTeresa Cejalvo, Ana Judith Perisé-Barrios, Isabel Del Portillo, et al.
Neoplasia (New York, N.Y.)|October 7, 2005
Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenovirusesHong Jiang, Ramon Alemany, Candelaria Gomez-Manzano, et al.
Journal of Virology|October 23, 2015
Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In VivoAnne K Zaiss, Erin M Foley, Roger Lawrence, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2005
Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancerDaniëlle A M Heideman, Renske D M Steenbergen, Jaco van der Torre, et al.
Elife|March 11, 2025
Unraveling the power of NAP-CNB's machine learning-enhanced tumor neoantigen predictionAlmudena Mendez-Perez, Andres M Acosta-Moreno, Carlos Wert-Carvajal, et al.
Neurosurgery|December 25, 2004
Oncolytic virotherapy of meningiomas in vitro with replication-competent adenovirusJacques Grill, Martine L M Lamfers, Victor W van Beusechem, et al.
Frontiers in Oncology|December 6, 2023
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse modelMariangela Garofalo, Magdalena Wieczorek, Ines Anders, et al.
Cancer Research|March 13, 2002
Treatment of ovarian cancer with a tropism modified oncolytic adenovirusGerd J Bauerschmitz, John T Lam, Anna Kanerva, et al.
Human Gene Therapy|August 29, 2025
Toxicity and Biodistribution of the Oncolytic Virus VCN-01 Following Intracranial Injection in Syrian HamstersDaniel Palacios-Alonso, Miriam Bazan-Peregrino, Marta Zalacain, et al.
Oncogene|March 12, 2004
A novel E1A-E1B mutant adenovirus induces glioma regression in vivoCandelaria Gomez-Manzano, Cristina Balague, Ramon Alemany, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
Cancer Research|July 12, 2018
Remission of Spontaneous Canine Tumors after Systemic Cellular ViroimmunotherapyTeresa Cejalvo, Ana Judith Perisé-Barrios, Isabel Del Portillo, et al.
Neoplasia (New York, N.Y.)|October 7, 2005
Downmodulation of E1A protein expression as a novel strategy to design cancer-selective adenovirusesHong Jiang, Ramon Alemany, Candelaria Gomez-Manzano, et al.
Journal of Virology|October 23, 2015
Hepatocyte Heparan Sulfate Is Required for Adeno-Associated Virus 2 but Dispensable for Adenovirus 5 Liver Transduction In VivoAnne K Zaiss, Erin M Foley, Roger Lawrence, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 9, 2005
Oncolytic adenovirus expressing a p53 variant resistant to degradation by HPV E6 protein exhibits potent and selective replication in cervical cancerDaniëlle A M Heideman, Renske D M Steenbergen, Jaco van der Torre, et al.
Elife|March 11, 2025
Unraveling the power of NAP-CNB's machine learning-enhanced tumor neoantigen predictionAlmudena Mendez-Perez, Andres M Acosta-Moreno, Carlos Wert-Carvajal, et al.
Neurosurgery|December 25, 2004
Oncolytic virotherapy of meningiomas in vitro with replication-competent adenovirusJacques Grill, Martine L M Lamfers, Victor W van Beusechem, et al.
Frontiers in Oncology|December 6, 2023
Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse modelMariangela Garofalo, Magdalena Wieczorek, Ines Anders, et al.
Cancer Research|March 13, 2002
Treatment of ovarian cancer with a tropism modified oncolytic adenovirusGerd J Bauerschmitz, John T Lam, Anna Kanerva, et al.
Human Gene Therapy|August 29, 2025
Toxicity and Biodistribution of the Oncolytic Virus VCN-01 Following Intracranial Injection in Syrian HamstersDaniel Palacios-Alonso, Miriam Bazan-Peregrino, Marta Zalacain, et al.
Oncogene|March 12, 2004
A novel E1A-E1B mutant adenovirus induces glioma regression in vivoCandelaria Gomez-Manzano, Cristina Balague, Ramon Alemany, et al.
Pageof 10